[November 18, 2014]

Research and Markets: Global Peanut Allergy Clinical Trials Review 2014 - Analysis of Top 7 Companies & 10 Institutes

Research and Markets (http://www.researchandmarkets.com/research/2lqll3/peanut_allergy) has announced the addition of the "Peanut Allergy Global Clinical Trials Review, H2, 2014" report to their offering.

This report provides elemental information and data relating to the clinical trials on Peanut Allergy. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trias for the key drugs for treating Peanut Allergy.

Scope

• Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
• Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
• Listings of discontinued trials (suspended, withdrawn and terminated)

Clinical Trial Overview of Top Companies

• DBV Technologies SA
• F. Hoffmann-La Roche Ltd.
• Novartis AG
• Allergen Research Corporation
• Immunomic Therapeutics, Inc.
• HAL Allergy BV
• Allertein Therapeutics, LLC

Clinical Trial Overview of Top Institutes / Government

• The National Institute of Allergy and Infectious Diseases
• The University of North Carolina at Chapel Hill
• University of North Carolina
• Johns Hopkins University
• Massachusetts General Hospital
• Boston Children's Hospital
• Baylor College of Medicine
• McMaster University
• Hamilton Health Sciences
• Karolinska Institute

For more information visit http://www.researchandmarkets.com/research/2lqll3/peanut_allergy

[ Back To TMCnet.com's Homepage ]